Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Clinical Investigation

  • Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with <sup>18</sup>F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study
    You have access
    Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with 18F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study
    Andreas G. Wibmer, Michael J. Morris, Mithat Gonen, Junting Zheng, Hedvig Hricak, Steven Larson, Howard I. Scher and Hebert Alberto Vargas
    Journal of Nuclear Medicine August 1, 2021, 62 (8) 1050-1056; DOI: https://doi.org/10.2967/jnumed.120.256602
  • Evaluation of Safety and Dosimetry of <sup>177</sup>Lu-DOTA-ZOL for Therapy of Bone Metastases
    Open Access
    Evaluation of Safety and Dosimetry of 177Lu-DOTA-ZOL for Therapy of Bone Metastases
    René Fernández, Elisabeth Eppard, Wencke Lehnert, Luis David Jiménez-Franco, Cristian Soza-Ried, Matías Ceballos, Jessica Ribbeck, Andreas Kluge, Frank Rösch, Marian Meckel, Konstantin Zhernosekov, Vasko Kramer and Horacio Amaral
    Journal of Nuclear Medicine August 1, 2021, 62 (8) 1126-1132; DOI: https://doi.org/10.2967/jnumed.120.255851
  • Simulation of Low-Dose Protocols for Myocardial Perfusion <sup>82</sup>Rb Imaging
    You have access
    Simulation of Low-Dose Protocols for Myocardial Perfusion 82Rb Imaging
    Martin Lyngby Lassen, Yuka Otaki, Paul Kavanagh, Robert J.H. Miller, Daniel S. Berman and Piotr J. Slomka
    Journal of Nuclear Medicine August 1, 2021, 62 (8) 1112-1117; DOI: https://doi.org/10.2967/jnumed.120.252429
  • Lymph Node Staging with a Combined Protocol of <sup>18</sup>F-FDG PET/MRI and Sentinel Node SPECT/CT: A Prospective Study in Patients with FIGO I/II Cervical Carcinoma
    You have access
    Lymph Node Staging with a Combined Protocol of 18F-FDG PET/MRI and Sentinel Node SPECT/CT: A Prospective Study in Patients with FIGO I/II Cervical Carcinoma
    Matthias Weissinger, Florin-Andrei Taran, Sergios Gatidis, Stefan Kommoss, Konstantin Nikolaou, Samine Sahbai, Christian la Fougère, Sara Yvonne Brucker and Helmut Dittmann
    Journal of Nuclear Medicine August 1, 2021, 62 (8) 1062-1067; DOI: https://doi.org/10.2967/jnumed.120.255919
  • Radiation Dosimetry of <sup>99m</sup>Tc-PSMA I&amp;S: A Single-Center Prospective Study
    You have access
    Radiation Dosimetry of 99mTc-PSMA I&S: A Single-Center Prospective Study
    Szabolcs Urbán, Catherine Meyer, Magnus Dahlbom, István Farkas, Gábor Sipka, Zsuzsanna Besenyi, Johannes Czernin, Jeremie Calais and László Pávics
    Journal of Nuclear Medicine August 1, 2021, 62 (8) 1075-1081; DOI: https://doi.org/10.2967/jnumed.120.253476
  • PET/CT-Guided Biopsy of Suspected Lung Lesions Requires Less Rebiopsy Than CT-Guided Biopsy Due to Inconclusive Results
    You have access
    PET/CT-Guided Biopsy of Suspected Lung Lesions Requires Less Rebiopsy Than CT-Guided Biopsy Due to Inconclusive Results
    Juliano J. Cerci, Mateos Bogoni, Rodrigo J. Cerci, Margaret Masukawa, Carlos C.P. Neto, Cassiano Krauzer, Stefano Fanti, Danielle G. Sakamoto, Renan B. Barreiros, Cristina Nanni and João V Vitola
    Journal of Nuclear Medicine August 1, 2021, 62 (8) 1057-1061; DOI: https://doi.org/10.2967/jnumed.120.252403
  • Interim PET in Diffuse Large B-Cell Lymphoma
    You have access
    Interim PET in Diffuse Large B-Cell Lymphoma
    Lars Kurch, Andreas Hüttmann, Thomas W. Georgi, Jan Rekowski, Osama Sabri, Christine Schmitz, Regine Kluge, Ulrich Dührsen and Dirk Hasenclever
    Journal of Nuclear Medicine August 1, 2021, 62 (8) 1068-1074; DOI: https://doi.org/10.2967/jnumed.120.255034
  • You have access
    A Bright Future for Nuclear Endocrinology
    David Taïeb, Elif Hindié and David Mankoff
    Journal of Nuclear Medicine July 1, 2021, 62 (Supplement 2) 1S-2S; DOI: https://doi.org/10.2967/jnumed.120.246074
  • You have access
    Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?
    Damian Wild, Kwadwo Antwi, Melpomeni Fani and Emanuel R. Christ
    Journal of Nuclear Medicine July 1, 2021, 62 (Supplement 2) 44S-50S; DOI: https://doi.org/10.2967/jnumed.120.246009
  • You have access
    A Clinical Challenge: Endocrine and Imaging Investigations of Adrenal Masses
    Anders Sundin, Elif Hindié, Anca M. Avram, Antoine Tabarin, Karel Pacak and David Taïeb
    Journal of Nuclear Medicine July 1, 2021, 62 (Supplement 2) 26S-33S; DOI: https://doi.org/10.2967/jnumed.120.246066

Pages

  • Previous
  • Next
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 50
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire